Hyelim Cho
VP, Head of Strategy
Actithera
Bio:
Hyelim Cho is VP, Head of Strategy at Actithera, a radioligand therapy company, where she drives portfolio strategy, early asset prioritization, and cross‑functional alignment between science and business. Previously, she served as Senior Director of Business Development and Alliance Management at RayzeBio (a Bristol Myers Squibb company), leading Search & Evaluation efforts in oncology and radiopharmaceuticals to identify, evaluate, and advance external opportunities aligned with corporate strategy and portfolio priorities. With experience spanning R&D, S&E, and BD, Hyelim brings a pragmatic approach to defining early “must‑have” criteria, pressure‑testing differentiation, and enabling high‑conviction early deal decisions.